[Antimigrainous agents. General considerations and treatment of the crisis].
Massiou
H
H
Bousser
M G
MG
D015670:Acupuncture Therapy; D000639:Amitriptyline / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000932:Antiemetics / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D004087:Dihydroergotamine / Q000627:therapeutic use; D004878:Ergotamine; D004879:Ergotamines / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000628:therapy
D000700:Analgesics; D014151:Anti-Anxiety Agents; D000893:Anti-Inflammatory Agents; D000932:Antiemetics; D004879:Ergotamines; D000639:Amitriptyline; D002110:Caffeine; D004087:Dihydroergotamine; D004878:Ergotamine
Les antimigraineux. Généralités et traitement de la crise.